Prelude Therapeutics Inc

PRLDNASDAQ · USD
4.87USD0.00 (+6.57%)
1510

Prelude Therapeutics Inc (PRLD) Options Open Interest

PRLD options open interest is 4,163 contracts. The 2-week average daily volume is 89 contracts across the chain.

Read more

Monitoring PRLD open interest helps you see where real money is positioned on Prelude Therapeutics Inc's options and which strikes are attracting the most commitment from traders. Prelude Therapeutics Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor PRLD options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising PRLD options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Prelude Therapeutics Inc to settle.

Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid tumors, including glioblastoma multiforme. The company is also developing PRT1419, a potent and selective inhibitor of the anti-apoptotic protein; PRT2527, a potent inhibitor of CDK9 that exhibits high kinome selectivity; PRT-SCA2, which is in preclinical stage for multiple genomically selected cancers; PRT3645, a brain penetrant molecule that potently and selectively targets CDK4/6; and PRT-K4 that is in preclinical stage for solid tumors.

The company was incorporated in 2016 and is headquartered in Wilmington, Delaware.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where PRLD open interest is concentrated. Our scanner maps Prelude Therapeutics Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Prelude Therapeutics Inc's options open interest as the signal it is, not as an afterthought.

2026-10-16
Calls
7.500.700.70278%+0.4044204
5.000.150.850.50129%+0.477020
10.001.001.00401%+0.44692
2.501.652.652.15168%+0.93650
12.501.001.00445%+0.42780
Puts
5.000.501.350.93132%-0.520425
7.502.403.402.9015%-1.00007
2.500.500.50347%-0.13360
10.004.905.905.4097%-0.99680
12.507.608.608.10262%-0.84100

As of September 18, 2026

Follow the money

Track PRLD open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.

Start your 14-day free trial